Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Erectile Dysfunction
NCT06264635Phase 1Recruiting
- Sponsor
- University of Manitoba
- Start
- Jan 2025
- Primary completion
- Mar 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of platelet-rich plasma in erectile dysfunction (ED) (2 arms), sponsored by University of Manitoba. Primary endpoint: International Index of Erectile Function. Started Jan 2025; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT06264635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06264635.